These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31899373)

  • 1. Role of cytochrome P450-derived, polyunsaturated fatty acid mediators in diabetes and the metabolic syndrome.
    Dos Santos LRB; Fleming I
    Prostaglandins Other Lipid Mediat; 2020 Jun; 148():106407. PubMed ID: 31899373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid mediators generated by the cytochrome P450-Epoxide hydrolase pathway.
    Frömel T; Hu J; Fleming I
    Adv Pharmacol; 2023; 97():327-373. PubMed ID: 37236763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Pancreatic Carcinoma Growth Through Enhancing ω-3 Epoxy Polyunsaturated Fatty Acid Profile by Inhibition of Soluble Epoxide Hydrolase.
    Xia R; Sun L; Liao J; Li H; You X; Xu D; Yang J; Hwang SH; Jones RD; Hammock B; Yang GY
    Anticancer Res; 2019 Jul; 39(7):3651-3660. PubMed ID: 31262891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of soluble epoxide hydrolase modulates inflammation and autophagy in obese adipose tissue and liver: role for omega-3 epoxides.
    López-Vicario C; Alcaraz-Quiles J; García-Alonso V; Rius B; Hwang SH; Titos E; Lopategi A; Hammock BD; Arroyo V; Clària J
    Proc Natl Acad Sci U S A; 2015 Jan; 112(2):536-41. PubMed ID: 25550510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Consequences of Soluble Epoxide Hydrolase Deletion on Tumorigenesis and Metastasis in a Mouse Model of Breast Cancer.
    Kesavan R; Frömel T; Zukunft S; Brüne B; Weigert A; Wittig I; Popp R; Fleming I
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Individual Circulating FFAs on Plasma and Hepatic FFA Epoxides, Diols, and Epoxide-Diol Ratios as Indices of Soluble Epoxide Hydrolase Activity.
    Oh YT; Yang J; Morisseau C; He Q; Hammock B; Youn JH
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome P450 epoxygenase pathway of polyunsaturated fatty acid metabolism.
    Spector AA; Kim HY
    Biochim Biophys Acta; 2015 Apr; 1851(4):356-65. PubMed ID: 25093613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The factor in EDHF: Cytochrome P450 derived lipid mediators and vascular signaling.
    Fleming I
    Vascul Pharmacol; 2016 Nov; 86():31-40. PubMed ID: 26975734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytochrome P450-derived fatty acid epoxides and diols in angiogenesis and stem cell biology.
    Frömel T; Naeem Z; Pirzeh L; Fleming I
    Pharmacol Ther; 2022 Jun; 234():108049. PubMed ID: 34848204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacology of the cytochrome P450 epoxygenase/soluble epoxide hydrolase axis in the vasculature and cardiovascular disease.
    Fleming I
    Pharmacol Rev; 2014 Oct; 66(4):1106-40. PubMed ID: 25244930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fatty acid epoxides in the regulation of the inflammation].
    Kytikova OY; Denisenko YK; Novgorodtseva TP; Bocharova NV; Kovalenko IS
    Biomed Khim; 2022 Jun; 68(3):177-189. PubMed ID: 35717582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Lipid Mediators in Retinal Angiogenesis and Retinopathy.
    Fleming I
    Front Pharmacol; 2019; 10():739. PubMed ID: 31333461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulation of soluble epoxide hydrolase and lipidomic profiles in anorexia nervosa.
    Shih PB; Yang J; Morisseau C; German JB; Zeeland AA; Armando AM; Quehenberger O; Bergen AW; Magistretti P; Berrettini W; Halmi KA; Schork N; Hammock BD; Kaye W
    Mol Psychiatry; 2016 Apr; 21(4):537-46. PubMed ID: 25824304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioprotective mechanisms of cytochrome P450 derived oxylipins from ω-3 and ω-6 PUFAs.
    Cho C; Aliwarga T; Wiley AM; Totah RA
    Adv Pharmacol; 2023; 97():201-227. PubMed ID: 37236759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble epoxide hydrolase: A potential target for metabolic diseases.
    He J; Wang C; Zhu Y; Ai D
    J Diabetes; 2016 May; 8(3):305-13. PubMed ID: 26621325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whatever happened to the epoxyeicosatrienoic Acid-like endothelium-derived hyperpolarizing factor? The identification of novel classes of lipid mediators and their role in vascular homeostasis.
    Frömel T; Fleming I
    Antioxid Redox Signal; 2015 May; 22(14):1273-92. PubMed ID: 25330284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytochrome P450 derived epoxidized fatty acids as a therapeutic tool against neuroinflammatory diseases.
    Atone J; Wagner K; Hashimoto K; Hammock BD
    Prostaglandins Other Lipid Mediat; 2020 Apr; 147():106385. PubMed ID: 31698143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity is positively associated with arachidonic acid-derived 5- and 11-hydroxyeicosatetraenoic acid (HETE).
    Pickens CA; Sordillo LM; Zhang C; Fenton JI
    Metabolism; 2017 May; 70():177-191. PubMed ID: 28403941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisallylic hydroxylation and epoxidation of polyunsaturated fatty acids by cytochrome P450.
    Oliw EH; Bylund J; Herman C
    Lipids; 1996 Oct; 31(10):1003-21. PubMed ID: 8898299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytochrome P450-dependent eicosanoid production and crosstalk.
    Fleming I
    Curr Opin Lipidol; 2011 Oct; 22(5):403-9. PubMed ID: 21825980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.